Acceptability of self-sample human papillomavirus testing among transmasculine people

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20240427010

Enrollment

227

Registered

2024-04-27

Start date

2024-08-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

human papillomavirus infection transgender men human papilloma virus HPV

Interventions

adult transgender men age 25-65 years

Screening

adult transgender men

Eligibility

Sex/Gender

Female

Age

25 Years to 65 Years

Inclusion criteria

Inclusion criteria: Transmasculine diagnosed with gender dysphoria (based on DSM-5) Ages 25-65 years old visiting at Gender Health Clinic Willing and able to provide informed consent. Willing to provide information Fluent in Thai language

Exclusion criteria

Exclusion criteria: Abnormal uterine or vaginal bleeding History or current abnormal cervical cytology Has undergone metoidioplasty Has undergone hysterectomy Pregnancy

Design outcomes

Primary

Measure	Time frame
To assess the acceptability of self-collected high risk HPV testing among transgender men at time visiting OPD questionnaire	—

Secondary

Measure	Time frame
To evaluate the barriers to healthcare screening systems among transgender men at time visiting OPD Questionnaire,o compare the acceptability of self and provider-collected high risk HPV testing at time visiting OPD Questionaire	—

Countries

Thailand

Contacts

Public ContactWipada Penroj

Chulalongkorn University

pick1707@docchula.com0850458234

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026